| Literature DB >> 36212454 |
Pi-Xiao Zhou1,2, Shu-Xu Zhang1.
Abstract
Radiotherapy plays an irreplaceable and unique role in treating thoracic tumors, but the occurrence of radiation-induced lung injury has limited the increase in tumor target doses and has influenced patients' quality of life. However, the introduction of functional lung imaging has been incorporating functional lungs into radiotherapy planning. The design of the functional lung protection plan, while meeting the target dose requirements and dose limitations of the organs at risk (OARs), minimizes the radiation dose to the functional lung, thus reducing the occurrence of radiation-induced lung injury. In this manuscript, we mainly reviewed the lung ventilation or/and perfusion functional imaging modalities, application, and progress, as well as the results based on the functional lung protection planning in thoracic tumors. In addition, we also discussed the problems that should be explored and further studied in the practical application based on functional lung radiotherapy planning.Entities:
Keywords: four-dimensional CT; functional lung; magnetic resonance imaging (MRI); perfusion (Q); positron emission tomography (PET); radiotherapy; single-photon emission computed tomography (SPECT); ventilation (V)
Year: 2022 PMID: 36212454 PMCID: PMC9544588 DOI: 10.3389/fonc.2022.908345
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 5.738
Figure 1Lung ventilation function images obtained by different ventilation imaging algorithms (VIAs). (A) ΔV; (B) Jacobian; (C) HU. Reproduced from reference (43) with permission from Wiley, copyright 2013.
Figure 2Quantitative maps of ventilation and perfusion calculated using the matrix pencil (MP) and Fourier decomposition (FD) methods. (A, C), MP-MRI ventilation/perfusion; (B, D), FD-MRI ventilation/perfusion. Reproduced from reference (64) with permission from Wiley, copyright 2016.
Figure 3Examples of the standard and functional plans with VMAT (top) and three-field IMPT (bottom) techniques. The yellow arrow indicates where the most functional sparing occurs for this patient. Reproduced from reference (90) with permission from Wiley, copyright 2021.
Registered clinical trials of functional lung sparing planning-guided radiotherapy (from ClinicalTrials.gov).
| Author | ID | Phase | Statue | Last updated | Characteristics | Modalities | Objective (lung) | Institutions |
|---|---|---|---|---|---|---|---|---|
| Huang et al. ( | NCT05134558 | – | Recruiting | November 2021 | Lung cancer | CT (Xenon) | RILI | National Taiwan University Hospital |
| Filion et al. ( | NCT04863027 | I–II | Recruiting | April 2021 | Lung cancer | DECT | RILI | Centre Hospitalier de l’Université de Montréal |
| Yamamoto et al. ( | NCT02308709 | – | Active, not recruiting | August 2021 | Lung cancer | 4DCT | RILI | University of California, Davis |
| Hsu et al. ( | NCT03077854 | – | Recruiting | March 2019 | NSCLC (III) or SCLC (Limited Stage) | 4DCT | RILI | National Taiwan University Hospital |
| Bayouth et al. ( | NCT02843568 | – | Recruiting | June 2021 | NSCLC | 4DCT | RILI | University of Wisconsin Carbone Cancer Center |
| Vinogradskiy et al. ( | NCT02528942 | II | Completed | July 2021 | Lung cancer | 4DCT | RP (2+) | University of Colorado Cancer Center |
| Yaremko et al. ( | NCT02002052 | II | Terminated (insufficient) | September 2019 | NSCLC (III A-B) | MRI (3He) | RILI | London Health Sciences Centre |
| Zeng et al. ( | NCT02773238 | II | Active, not recruiting | January 2022 | NSCLC (II B–III B) | SPECT/CT (99mTC-SC, 99mTC-MAA) | RP (2+) | University of Washington |
| Farr et al. ( | NCT01745484 | – | Completed | April 2019 | NSCLC (I–III) | SPECT/CT (–) | RP (2+) | Aarhus University Hospital |
| Farr et al. ( | NCT04676828 | II | Recruiting | January 2021 | Lung cancer | SPECT/CT (–) | RP (2+) | Aarhus University Hospital |
| Rachel et al. ( | NCT04942275 | II–III | Recruiting | July 2021 | NSCLC | PET/CT (68Ga-MAA) | RILI | University Hospital, Brest |
| Bucknell et al. ( | NCT03569072 | – | Recruiting | September 2020 | NSCLC (III A–C) | PET/CT (18F-FDG) | RILI | Peter MacCallum Cancer Centre |
NSCLC, nonsmall cell lung cancer; RT, radiotherapy; SBRT, stereotactic body radiotherapy; SABR, hypofractionated stereotactic ablative radiotherapy; PFT, pulmonary function test; PDFT, pulmonary diffusion function test; RILI, radiation-induced lung injury; RP, radiation pneumonitis; 99mTC-SC, technetium Tc-99m sulfur colloid; 99mTC-MAA, technetium Tc-99m albumin aggregated; 68Ga-MAA, human albumin macroaggregates labeled with Ga-68; 18F-FDG, 18F-2-fluoro-2-deoxy-d-glucose fluorodeoxyglucose.
Figure 468Ga PET/CT ventilation and perfusion images and voxel-wise correlations between ventilation and perfusion for two representative patients: case 1 with the highest correlation (r = 0.88) and case 19 with the lowest correlation (r = 0.26). Reproduced from reference (111) with permission from Elsevier, copyright 2022.